BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 34968919)

  • 1. Dysregulated expression and functions of microRNA-330 in cancers: A potential therapeutic target.
    Jafarzadeh A; Paknahad MH; Nemati M; Jafarzadeh S; Mahjoubin-Tehran M; Rajabi A; Shojaie L; Mirzaei H
    Biomed Pharmacother; 2022 Feb; 146():112600. PubMed ID: 34968919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142-3p and miR-129-5p.
    Liu K; Huang J; Ni J; Song D; Ding M; Wang J; Huang X; Li W
    Cell Cycle; 2017 Mar; 16(6):578-587. PubMed ID: 28346809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging roles of the long non-coding RNA 01296/microRNA-143-3p/MSI2 axis in development of thyroid cancer.
    Wang ZL; Wang C; Liu W; Ai ZL
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31693087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors.
    Fu XP; Ji CY; Tang WQ; Yu TT; Luo L
    Clin Exp Med; 2024 May; 24(1):93. PubMed ID: 38693424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA LINC01234 silencing exerts an anti-oncogenic effect in esophageal cancer cells through microRNA-193a-5p-mediated CCNE1 downregulation.
    Ma J; Han LN; Song JR; Bai XM; Wang JZ; Meng LF; Li J; Zhou W; Feng Y; Feng WR; Ma JJ; Hao JT; Shen ZQ
    Cell Oncol (Dordr); 2020 Jun; 43(3):377-394. PubMed ID: 32130660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p) coordinately targeted MTDH in lung squamous cell carcinoma.
    Mataki H; Seki N; Mizuno K; Nohata N; Kamikawaji K; Kumamoto T; Koshizuka K; Goto Y; Inoue H
    Oncotarget; 2016 Nov; 7(44):72084-72098. PubMed ID: 27765924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of UHRF1 by dual-strand tumor-suppressor microRNA-145 (miR-145-5p and miR-145-3p): Inhibition of bladder cancer cell aggressiveness.
    Matsushita R; Yoshino H; Enokida H; Goto Y; Miyamoto K; Yonemori M; Inoguchi S; Nakagawa M; Seki N
    Oncotarget; 2016 May; 7(19):28460-87. PubMed ID: 27072587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-101-3p and miR-199b-5p promote cell apoptosis in oral cancer by targeting BICC1.
    Wang H; Guo Y; Mi N; Zhou L
    Mol Cell Probes; 2020 Aug; 52():101567. PubMed ID: 32259627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles and mechanisms of miR-195-5p in human solid cancers.
    Xu Q; Xu JL; Chen WQ; Xu WX; Song YX; Tang WJ; Xu D; Jiang MP; Tang J
    Biomed Pharmacother; 2022 Jun; 150():112885. PubMed ID: 35453003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA GAS5 Suppresses the Proliferation and Invasion of Osteosarcoma Cells via the miR-23a-3p/PTEN/PI3K/AKT Pathway.
    Liu J; Chen M; Ma L; Dang X; Du G
    Cell Transplant; 2020; 29():963689720953093. PubMed ID: 33121268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA A1BG-AS1 promotes tumorigenesis in breast cancer by sponging microRNA-485-5p and consequently increasing expression of FLOT1 expression.
    Cai S; Zhou Y; Pan Y; Liu P; Yu K; Chen S
    Hum Cell; 2021 Sep; 34(5):1517-1531. PubMed ID: 34115333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-sequence-based microRNA expression signature in breast cancer: tumor-suppressive miR-101-5p regulates molecular pathogenesis.
    Toda H; Seki N; Kurozumi S; Shinden Y; Yamada Y; Nohata N; Moriya S; Idichi T; Maemura K; Fujii T; Horiguchi J; Kijima Y; Natsugoe S
    Mol Oncol; 2020 Feb; 14(2):426-446. PubMed ID: 31755218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA PRNCR1 modulates non-small cell lung cancer cell proliferation, apoptosis, migration, invasion, and EMT through PRNCR1/miR-126-5p/MTDH axis.
    Guo R; Hu T; Liu Y; He Y; Cao Y
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 31912882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA LUCAT1/miR-181a-5p axis promotes proliferation and invasion of breast cancer via targeting KLF6 and KLF15.
    Liu Y; Cheng T; Du Y; Hu X; Xia W
    BMC Mol Cell Biol; 2020 Sep; 21(1):69. PubMed ID: 32998707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-324 in Human Cancer: miR-324-5p and miR-324-3p Have Distinct Biological Functions in Human Cancer.
    Kuo WT; Yu SY; Li SC; Lam HC; Chang HT; Chen WS; Yeh CY; Hung SF; Liu TC; Wu T; Yu CC; Tsai KW
    Anticancer Res; 2016 Oct; 36(10):5189-5196. PubMed ID: 27798879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA RP11-116G8.5 promotes the progression of lung squamous cell carcinoma through sponging miR-3150b-3p/miR-6870-5p to upregulate PHF12/FOXP4.
    Li H; Zhao Q; Tang Z
    Pathol Res Pract; 2021 Oct; 226():153566. PubMed ID: 34500373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA DLEU1 aggravates osteosarcoma carcinogenesis via regulating the miR-671-5p/DDX5 axis.
    Chen X; Zhang C; Wang X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3322-3328. PubMed ID: 31379208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of long noncoding RNA LINC00958 prevents tumor initiation of pancreatic cancer by acting as a sponge of microRNA-330-5p to down-regulate PAX8.
    Chen S; Chen JZ; Zhang JQ; Chen HX; Qiu FN; Yan ML; Tian YF; Peng CH; Shen BY; Chen YL; Wang YD
    Cancer Lett; 2019 Apr; 446():49-61. PubMed ID: 30639194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.